On November 1, 2025, Mr. Huang Bisheng, Chairman of Zhejiang Tianyuan Biotechnology Co., Ltd., and Mr. Jiao Mingming, General Manager, were invited to attend the High-Quality Development Conference for the Centennial of Ningbo College of Health Sciences, as well as the Yangtze River Delta Dermatology Forum & Academic Conference of the Cosmetics Committee of the Zhejiang Pharmaceutical Association. They extended their congratulations on the college’s centennial anniversary and shared the company’s insights and experience in scientific research collaboration.

      Centennial Celebration: A Grand Gathering. On the morning of November 1, the High-Quality Development Conference for the Centennial of Ningbo College of Health Sciences was grandly held. Faculty members, students, alumni from home and abroad, and distinguished guests from all sectors gathered to review the college’s century-long journey and envision its future. Chairman Huang Bisheng and General Manager Jiao Mingming attended the event in person to convey sincere congratulations on behalf of Tianyuan Biotech, expressing their hope to deepen cooperation with the college in talent cultivation and scientific innovation, and to advance hand in hand.

      Focusing on Dermatological Science: Exploring Cutting-Edge Developments. In the afternoon, at the invitation of President Jin Litai, General Manager Jiao Mingming attended the Yangtze River Delta Dermatology Forum & Academic Conference of the Cosmetics Committee of the Zhejiang Pharmaceutical Association. As a panelist in the roundtable session, he engaged in discussions on topics including new paradigms in clinical dermatology diagnosis and treatment, innovative applications of cytokines in aesthetics, and cutting-edge R&D in cosmetic technologies. The forum integrated academic frontiers with practical guidance, offering fresh perspectives for industry development.

      Upholding a philosophy of open collaboration, Tianyuan Biotech actively participates in academic exchanges and research partnerships. The company welcomes universities, research institutes, hospitals, and other institutions to join hands in exploring new avenues for scientific cooperation, making unremitting efforts toward the cause of human health.

      Founded in 2017, Zhejiang Tianyuan Biotechnology Co., Ltd. is a national high-tech enterprise dedicated to cell research and development, manufacturing, operations, and services. The company possesses valuable resource banks, including an HLA Umbilical Cord Matching Bank, an iPS Seed Cell Bank, and a Cancer Cell Bank. It is also a participating unit in formulating the group standard for immune function assessment methods under the National Health Commission (NHC). Furthermore, Tianyuan Biotech has co-established the Joint Laboratory for Metabolic Immune Monitoring with the NHC Research Institute, and serves as key research service platforms such as the Ningbo Storage Center of the National Stem Cell Translational Resource Bank and the Achievement Transformation Center of the NHC Research Institute.